Disc Medicine (IRON) Fundamental Analysis: Revenue, Earnings & Valuation

5.12 / 10

Netural

Fundamental analysis rates the stock neutral (5.1/10). Strengths include Cash‑MV, Inventory turnover, and PB‑ROE, while Revenue‑MV and Gross profit margin lag. Asset‑MV is modestly positive, suggesting mixed financial health.

Analysis Checks(8/10)

Revenue-MV

Value-0.11

Score1/3

Weight10.60%

1M Return4.95%

Total operating revenue (YoY growth rate %)

Value134.00

Score3/3

Weight2.74%

1M Return1.54%

Inventory turnover ratio

Value103.94

Score3/3

Weight14.07%

1M Return6.74%

Gross profit margin (%)

Value41.83

Score1/3

Weight-1.00%

1M Return-0.63%

PB-ROE

Value2.34

Score3/3

Weight22.06%

1M Return9.74%

Income tax / Total profit (%)

Value-0.17

Score2/3

Weight1.88%

1M Return1.04%

Fixed assets turnover ratio

Value9306.28

Score3/3

Weight1.81%

1M Return1.06%

Cost of sales ratio (%)

Value64.41

Score3/3

Weight8.14%

1M Return4.32%

Asset-MV

Value-0.55

Score2/3

Weight27.20%

1M Return12.22%

Cash-MV

Value0.02

Score2/3

Weight12.49%

1M Return5.94%

Is IRON fundamentally strong?

IRON scores 5.12/10 on fundamentals and holds a Fair valuation at present. Backed by its -35.86% ROE, 0.00% net margin, -11.66 P/E ratio, 3.34 P/B ratio, and -51.77% earnings growth, these metrics solidify its Netural investment rating.